I-123 Biomarker Committee: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
:Co-chairs: John Dickson, PhD; John Seibyl, MD | :Co-chairs: John Dickson, PhD; John Seibyl, MD | ||
* [http://tinyurl.com/QIBA-SPECT-Roster Roster] | * [http://tinyurl.com/QIBA-SPECT-I-123-Roster Roster] | ||
| Line 21: | Line 21: | ||
==QIBA Funded Projects== | ==QIBA Funded Projects== | ||
====Round 6==== | ====Round 6==== | ||
*[[Media:Multi-center Phantom Study to Characterize Bias and Precision of Quantitative I-123 SPECT.pdf | Project (V) Multi-center Phantom Study to Characterize Bias and Precision of Quantitative I-123 SPECT (University of Michigan)]] | |||
*[[Media:I-123 DAT Scan Digital Reference Object Development.pdf | Project (X) I-123 DAT Scan Digital Reference Object Development (University of Washington)]] | |||
Latest revision as of 18:47, 21 December 2023
- Co-chairs: John Dickson, PhD; John Seibyl, MD
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD